Devises / JAZZ
JAZZ: Jazz Pharmaceuticals plc
116.12
USD
0.53
(0.45%)
Le taux de change de JAZZ a changé de -0.45% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 115.29 et à un maximum de 117.15.
Suivez la dynamique Jazz Pharmaceuticals plc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
JAZZ Nouvelles
- Zacks Sarepta Therapeutics (SRPT) to Report Q2 Results: Wall Street Expects Earnings Growth
- Zacks Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
- Zacks Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
- Zacks ALKS Down Despite Positive Top-Line Data From Narcolepsy Study
- Seeking Alpha Polaris Global Equity Composite Q2 2025 Commentary
- Investor's Business Daily Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
- Seeking Alpha XPH: Healthcare Dashboard For July (NYSEARCA:XPH)
- Investing Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating
- Investor's Business Daily Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
- Investing Jazz Pharmaceuticals names Renee Gala as next CEO
- TipRanks 3 Must-Watch Stocks with a ‘Perfect 10’ Smart Score - TipRanks.com
- Investing Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating
- Seeking Alpha Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- Investing PharmaMar FY 2024 slides: Revenue up 11%, net profit soars amid clinical advances
- Investing Zymeworks stock holds steady as H.C. Wainwright reiterates Neutral rating
- Benzinga Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz - Avadel Pharmaceuticals (NASDAQ:AVDL)
- Investing European Commission approves Jazz Pharmaceuticals’ Ziihera for rare cancer
- Investing Avadel stock rises after appeals court upholds LUMRYZ approval
- Seeking Alpha STOK: Impressive Pipeline And Big Backers (NASDAQ:STOK)
- Seeking Alpha Amgen Stock: Imdelltra Data And Q1 Results Impress (NASDAQ:AMGN)
- Investing FDA grants priority review to Zepzelca combo for ES-SCLC
- Investing Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav ® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
- Seeking Alpha ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
- Seeking Alpha Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY)
Range quotidien
115.29
117.15
Range Annuel
95.49
148.06
- Clôture Précédente
- 116.60
- Ouverture
- 116.65
- Bid
- 116.12
- Ask
- 116.42
- Plus Bas
- 115.29
- Plus Haut
- 117.15
- Volume
- 1.206 K
- Changement quotidien
- -0.45%
- Changement Mensuel
- 10.16%
- Changement à 6 Mois
- -5.06%
- Changement Annuel
- 2.82%
31 juillet, jeudi
11:30
USD
- Act
- Fcst
- Prev
- 47.999 K
11:30
USD
- Act
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Act
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Act
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Act
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Act
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Act
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Act
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Act
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Act
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Act
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Act
- Fcst
- Prev
- 4.245%
15:30
USD
- Act
- Fcst
- Prev
- 4.265%